Skip to content

Silicone Oil Tamponade for Vitrectomy of Hypermyopic Foveoschisis.

A Prospective, Randomized, Controlled, Multicentered Study of Vitrectomy With Silicone Oil Tamponade for Hypermyopic Foveoschisis.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05628909
Enrollment
159
Registered
2022-11-29
Start date
2022-10-29
Completion date
2024-12-31
Last updated
2022-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypermyopic Foveoschisis

Brief summary

The purpose of this study is to explore the efficiency and safety of the surgical procedure of pars plana vitrectomy with silicone oil tamponade and without internal limiting membrane peeling for myopic foveoschisis eyes with high risk of macular hole formation.

Interventions

PROCEDUREPPV with SO tamponade

Patients randomized into silicone oil group were received pars plana vitrectomy surgery with silicone oil tamponade and without internal limiting membrane peeling. And silicone oil tamponade was removed at least 12 months after the primary surgery with completely resolved of foveoschisis.

PROCEDUREPPV with fovea-sparing ILMP and gas tamponade

Patients randomized into gas group 1 were received pars plana vitrectomy surgery with fovea-sparing internal limiting membrane peeling and gas tamponade.

PROCEDUREPPV with gas tamponade

Patients randomized into gas group 2 were received pars plana vitrectomy surgery without internal limiting membrane peeling and gas tamponade.

Sponsors

Beijing Tongren Hospital
CollaboratorOTHER
Peking Union Medical College Hospital
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Henan Provincial People's Hospital
CollaboratorOTHER
Beijing Friendship Hospital
CollaboratorOTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Huaxi Hospital
CollaboratorOTHER
Shenzhen Eye Hospital
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
Peking University Third Hospital
CollaboratorOTHER
Aier Eye Hospital, Beijing
CollaboratorUNKNOWN
Peking University First Hospital
CollaboratorOTHER
Xuanwu Hospital, Beijing
CollaboratorOTHER
China-Japan Friendship Hospital
CollaboratorOTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Eye & ENT Hospital of Fudan University
CollaboratorOTHER
Zhongshan Ophthalmic Center, Sun Yat-sen University
CollaboratorOTHER
The Eye Hospital of Wenzhou Medical University
CollaboratorOTHER
Zhejiang Provincial People's Hospital
CollaboratorOTHER
The First People's Hospital of Xuzhou
CollaboratorOTHER
The First Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
Second Hospital of Jilin University
CollaboratorOTHER
Xinjiang Production and Construction Corps Hospital
CollaboratorUNKNOWN
The Affiliated Hospital of Inner Mongolia Medical University
CollaboratorOTHER
The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Tianjin Medical University Eye Hospital
CollaboratorOTHER
Tianjin Medical University General Hospital
CollaboratorOTHER
Xinqiao Hospital of Chongqing
CollaboratorOTHER
Anhui Provincial Hospital
CollaboratorOTHER_GOV
Shengjing Hospital
CollaboratorOTHER
Lanzhou University Second Hospital
CollaboratorOTHER
The Fourth People's Hospital of Shenyang
CollaboratorUNKNOWN
The Second Hospital of Hebei Medical University
CollaboratorOTHER
The Second Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
The Affiliated Eye Hospital of Nanjing Medical University
CollaboratorUNKNOWN
Second Xiangya Hospital of Central South University
CollaboratorOTHER
Shandong Eye Hospital
CollaboratorOTHER
Renmin Hospital of Wuhan University
CollaboratorOTHER
First Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Shanghai 10th People's Hospital
CollaboratorOTHER
Wuhan General Hospital of Guangzhou Military Command
CollaboratorOTHER
Southwest Hospital, China
CollaboratorOTHER
First Affiliated Hospital of Kunming Medical University
CollaboratorOTHER
First Hospital of China Medical University
CollaboratorOTHER
Wuxi People's Hospital
CollaboratorOTHER
The First Affiliated Hospital Of Southwest University, China
CollaboratorUNKNOWN
Wuhan TongJi Hospital
CollaboratorOTHER
Shanghai Shi Bei Hospital
CollaboratorUNKNOWN
Tianjin Eye Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Xi'an People's Hospital (Xi'an Fourth Hospital)
CollaboratorOTHER
Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with spherical ≥ -8 diopters or axial length ≥ 26.5mm. * The foveoshisis combined with foveal detachment was showed on the OCT image. The foveal detachment height≥ 250 um ,and the thickness of sensory retina of foveal detachment was ≤100 um; * patients signed the ICF. * patients with BCVA ≤0.5,and with visual disturbance symptoms.

Exclusion criteria

* patients with macular hole * accompanied or secondary of other fundus disease * received vitrectomy due to other diseases * glaucoma cannot be controled by medication * patients with other retinal or choroidal disease that may affect VA * poor patients compliance * poor condition that cannot undertake the surgery * optical opacities which make it difficult to exam fundus or measure on OCT

Design outcomes

Primary

MeasureTime frameDescription
Complete resolved rate of foveoschisis observed on OCT image.18 monthsThe compete resolved of foveoschisis was evaluated using OCT image.

Secondary

MeasureTime frameDescription
Best corrected visual acuity (BCVA) change compared with baseline BCVA.18 monthsBest corrected visual acuity (BCVA) change compared with baseline BCVA by ETDRS chart.
The posoperative macular hole formation rate.18 monthsThe posoperative macular hole formation rate of different groups

Countries

China

Contacts

Primary ContactMingwei Zhao, M.D.
dr_mingweizhao@163.com13801057408

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026